Cargando…
Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma
There is a crosstalk between Tumor-associated macrophages (TAM) and tumor-infiltrating T cells in tumor environment. TAM could inhibit the activity of cytotoxic T cells; TAM could also regulate the composition of T cells in tumor immune environment. The combination therapy for TAM and tumor infiltra...
Autores principales: | Zhang, Wei, Jiang, Xi, Zou, Youcheng, Yuan, Lihua, Wang, Xiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030616/ https://www.ncbi.nlm.nih.gov/pubmed/36969873 http://dx.doi.org/10.3389/fphar.2023.1092767 |
Ejemplares similares
-
Tumor Secretion of CCL22 Activates Intratumoral Treg Infiltration and Is Independent Prognostic Predictor of Breast Cancer
por: Li, Ya-Qing, et al.
Publicado: (2013) -
Pexidartinib: First Approval
por: Lamb, Yvette N.
Publicado: (2019) -
CCL22 to activate Treg migration and suppress depigmentation in vitiligo
por: Eby, Jonathan M., et al.
Publicado: (2015) -
CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model
por: Wang, Qun, et al.
Publicado: (2022) -
Correction to: Pexidartinib: First Approval
por: Lamb, Yvette N.
Publicado: (2020)